Cite
HARVARD Citation
Zhang, M. et al. (2022). SIA-IgG confers poor prognosis and represents a novel therapeutic target in breast cancer. Bioengineered. 13 (4), pp. 10072-10087. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Zhang, M. et al. (2022). SIA-IgG confers poor prognosis and represents a novel therapeutic target in breast cancer. Bioengineered. 13 (4), pp. 10072-10087. [Online].